Scientists at the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center have made a surprising ...
SARS-CoV-2 BA.2.86 Is Less Resistant to Vaccine, but May Be a Problem in the Lung Jan. 8, 2024 — New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes ...
Driving recent surges in SARS-CoV-2 infection rates are mutations ... the Centers for Disease Control and Prevention reported the Omicron subvariant KP.3.1.1 accounted for most COVID-19 cases.
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Published in the journal PLOS Pathogens, this study is the first to identify an antibody that can both assist and block the virus.